Pfizer Q4 net profit falls 22% to Rs 68 cr

Published On 2017-05-08 12:17 GMT   |   Update On 2017-05-08 12:17 GMT

New Delhi: Drug firm Pfizer reported a 21.98 per cent dip in its standalone net profit at Rs 68.04 crore for the fourth quarter ended March 31, 2017. The company had posted a net profit of Rs 87.21 crore for the corresponding period of the previous fiscal, Pfizer Ltd said in a filing to BSE.


Standalone total income of the company for the quarter under consideration stood at Rs 481.97 crore as against Rs 563.57 crore in the same period a year ago.


For the fiscal year ended March 31, the net profit of the company stood at Rs 336.78 crore. It was Rs 304.99 crore during the preceding fiscal.


Total income of the company stood at Rs 2,143.09 crore for the fiscal year ended March 31.


Its total income during 2015-16 fiscal was at Rs 2,180.75 crore.


The board of directors of the company has recommended a normal dividend of Rs 15 per equity share of Rs 10 each and a special dividend of Rs 5 per share of Rs 10 each on account of exceptional income during the year for the financial year ended March 31, Pfizer said. PTI AKT ABI

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News